Executive Vice President, Research and Development · LEXICON PHARMACEUTICALS, INC. (LXRX)

Praveen Tyle

A named executive officer of LEXICON PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,609,821

Salary $483,159Stock awards $284,892Bonus $196,755

FY2019: $1,675,989

4th of 8 named executive officers at Lexicon Pharmaceuticals by FY2020 total.

8 named officers on file for LEXICON PHARMACEUTICALS, FY2020

Praveen Tyle’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • LXRX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how LEXICON PHARMACEUTICALS’s whole pay program stands against its peers

  • LEXICON PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LXRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 19, 2021 (DEF 14A).

Free

Get Praveen Tyle’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Praveen Tyle compensation by year

LEXICON PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held
In US dollars, as LEXICON PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$278,509$454,383$464,600$475,048$483,159
Bonus$182,500$165,645$160,903$192,426$196,755
Stock awards$0$172,702$285,672$486,765$284,892
Option awards$942,900$490,867$541,775$509,571$632,615
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$26,373$11,736$11,956$12,179$12,400
Total$1,430,282$1,295,333$1,464,906$1,675,989$1,609,821

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LEXICON PHARMACEUTICALS, INC. DEF 14A filed March 19, 2021, accession 0001062822-21-000016, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LEXICON PHARMACEUTICALS, INC. filed document, accession 0001062822-21-000016. Every figure is read from that document and cited to the page and table it appears in. Filed March 19, 2021.

$1.4M
$1.3M
$1.5M
$1.7M
$1.6M
FY16
FY17
FY18
FY19
FY20
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU86,070$294,359—
RSU53,200$181,944—
RSU9,727$33,266—
RSU2,990$10,226—
Option258,210—$3.31
Option1,984—$14.44
Option24,150—$9.79
Option80,269—$5.16

Per the Outstanding Equity Awards at Fiscal Year-End table in LEXICON PHARMACEUTICALS, INC.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

LEXICON PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Lonnel CoatsChief Executive Officer and Director$3,860,671
Pablo LapuertaFormer Executive Vice President and Chief Medical Officer$1,862,885
Jeffrey WadePresident and Chief Financial Officer$1,629,502
Praveen Tyle · this pageExecutive Vice President, Research and Development$1,609,821
Alexander SantiniFormer Executive Vice President and Chief Commercial Officer$1,354,036
Alan MainExecutive Vice President, Innovation and Chemical$1,305,309
Brian CrumSenior Vice President and General Counsel$1,209,201
Kenneth Kassler-TaubSenior Vice President, Regulatory and Quality$704,569

The full LEXICON PHARMACEUTICALS compensation record

free company brief

This page is one person within LEXICON PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the LEXICON PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LEXICON PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Praveen Tyle's compensation dossier · One-time report. No refunds.